ArticleActa pharmaceutica Sinica. B2025

Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Xiao-Mei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.